Center Laboratories, Inc. (TPEX:4123)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.30
-1.15 (-2.92%)
May 15, 2026, 1:30 PM CST
Market Cap29.45B +18.1%
Revenue (ttm)1.60B -1.8%
Net Income10.74B
EPS12.70
Shares Out746.53M
PE Ratio3.11
Forward PEn/a
Dividend0.71 (1.86%)
Ex-Dividend DateOct 3, 2025
Volume4,056,479
Average Volume2,908,345
Open39.75
Previous Close39.45
Day's Range38.30 - 39.75
52-Week Range33.10 - 51.40
Beta0.30
RSI41.40
Earnings DateApr 2, 2026

About Center Laboratories

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretic analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also provides central nervous system medication consisting of treatments for cerebrovascular disease, dementi... [Read more]

Sector Healthcare
Founded 1959
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4123
Full Company Profile

Financial Performance

Financial Statements